+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
MALE
Healthy Volunteers
ID06778083

Study on Antibiotic Use and Resistance in Men Who Have Sex with Men Using STI Prevention

Led by University College, London · Updated on 2025-03-27

108

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the risk of antibiotic resistance and changes in the human microbiome among men who have sex with men MSM using antibiotics to prevent sexually transmitted infections STI prophylaxis, specifically doxycycline post-exposure prophylaxis doxyPEP. This observational study aims to understand how antibiotic use affects bacteria in the throat and gut, focusing on the development of resistance and microbiome changes. The study will involve 108 MSM participants, some who use doxyPEP and others who do not. Participants will visit the clinic every six months, where they will provide throat swabs and stool samples. These samples will be analyzed for bacterial DNA to identify species and detect antibiotic resistance genes. The study allows all enrolled participants to use doxycycline post-exposure prophylaxis during the study period. Participants will complete questionnaires at each visit to provide additional information. Researchers will monitor changes in antimicrobial resistance genes and microbiome composition over 12 months. The main outcome is the detection and characterization of resistance genes and microbiome changes during this time. The study includes safety monitoring and continues until April 2027, with participants involved in regular assessments every six months.

CONDITIONS

Brief Title

STI Prophylaxis and Emergence of Antimicrobial Resistance

Research Team

M

Manik Kohli, MBChB MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here